CAC
CTOR

Cowen and Company’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History

Cowen and Company’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-627,176
Closed -$7.12M – 627
2024
Q2 		$7.12M Buy
627,176
+112,667
+22% +$1.28M 0.2% 45
2024
Q1 		$5.69M Buy
514,509
+443,432
+624% +$4.9M 0.22% 45
2023
Q4 		$778K Buy
71,077
+42,814
+151% +$468K 0.05% 169
2023
Q3 		$304K Buy
+28,263
New +$304K 0.02% 191